James E. Herndon

Also affiliated with Duke Institute for Health Innovation, Duke Medical Center, Duke University Health System, Institute of Bioinformatics, Duke University Hospital, Pediatric Brain Tumor Foundation, Duke Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial”.

Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial

Journal of Cachexia Sarcopenia and Muscle(2021)10.1002/jcsm.12828

N/A

1.5DataRank · unranked

49 citations

Samantha M. Thomas, James E. Herndon, Pamela S. Douglas, Anthony F. Yu, Valerie W. Rusch +10 more

Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial

The Lancet Child & Adolescent Health(2023)10.1016/s2352-4642(23)00031-7

N/A

1.2DataRank · unranked

48 citations

Daniel Landi, Michael C. Brown, Henry S. Friedman, Roger E. McLendon, James E. Herndon +15 more

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

Science Translational Medicine(2023)10.1126/scitranslmed.abn5649

N/A

0.853DataRank · unranked

30 citations

Charlotte McDowall, Luis Sánchez-Pérez, Cristina Osorio, Patrick C. Duncker, Aaron Briley +15 more

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

npj Vaccines(2021)10.1038/s41541-020-00273-5

N/A

0.425DataRank · unranked

16 citations

Kendra L. Congdon, Smita K. Nair, Qi-Jing Li, James E. Herndon, Carter M. Suryadevara +6 more

Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2005

N/A

0.373DataRank · unranked

11 citations

Kristen A. Batich, Duane A. Mitchell, James E. Herndon, Gloria Broadwater, Patrick Healy +15 more

A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14015

N/A

0.360DataRank · unranked

10 citations

Vidyalakshmi Chandramohan, Daniel Landi, Margaret Johnson, Mustafa Khasraw, Katherine B. Peters +12 more

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101166

N/A

0.345DataRank · unranked

9 citations

Andrew Fairchild, Justus Adamson, Peter E. Fecci, John H. Sampson, James E. Herndon +7 more

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1593

N/A

0.292DataRank · unranked

6 citations

Aaron C. Tan, Brent A. Hanks, Xiaofei Wang, Kouros Owzar, James E. Herndon +4 more

Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2566

N/A

0.269DataRank · unranked

5 citations

Dina Randazzo, Vidyalakshmi Chandramohan, Katherine B. Peters, Margaret Johnson, Stevie Threatt +10 more

Identifying predictive factors for radiation necrosis vs local recurrence in biopsy-proven enlarging lesions post-stereotactic radiosurgery for brain metastases

Neuro-Oncology Practice(2025)10.1093/nop/npaf125

N/A

0DataRank · unranked

2 citations

Aden Haskell-Mendoza, Ellery Reason, Joshua Jackson, Chunhao Wang, Eugene Vaios +5 more

Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum

UNC Libraries(2020)10.17615/8n5x-7b67

N/A

0DataRank · unranked

0 citations

James E. Herndon, Mark J. Haykowsky, April Coan, Edith Pituskin, Whitney Hornsby +6 more

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad095

N/A

0DataRank · unranked

11 citations

Hengshan Zhang, Anne-Marie Lyne, Florence M.G. Cavalli, Wafa E Hassen, Kevin Stevenson +10 more

Data from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

(2023)10.1158/1078-0432.c.6516909

N/A

0DataRank · unranked

0 citations

David A. Reardon, James E. Herndon, Jennifer Marcello, Jennifer A. Quinn, Jeremy N. Rich +9 more

Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1082

N/A

0DataRank · unranked

101 citations

Duane A. Mitchell, Patrick Healy, James E. Herndon, John H. Sampson, Kristen A. Batich